Sonoma Pharmaceuticals IncSNOA
Price$1.25Intrinsic value$1.195% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $19.5M+36.7% YoYTTM through 31 Mar 2026
Net Income -$3.2MTTM through 31 Mar 2026
Free Cash Flow -$4.1MTTM through 31 Mar 2026

Margins

Current
Gross Margin38.0%
Operating Margin-12.6%
Net Margin-16.3%

Returns

-84.6%ROE
-22.7%ROA

Balance Sheet Health

Debt / Equity0.07x
Net Debt-$1.6Mnet cash position
Cash & Equivalents$2.4M

Quality Metrics

FCF Margin-21.1%
Earnings-Beat Rate0.0%

Dividend

No dividend

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.